4
Changes in Ownership
Ernexa Therapeutics Inc. Filed Acc 0001019687-15-001090
Options or other derivatives
- CFO acquired 500,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Wolff Allen · CFO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2015-03-23 | Grant or award : show line 1 in the form Stock Options (Right to Buy) | +500,000 | 500,000 | D |
Loading xslF345X03/wolff_f4.xml…